SYNKIR Trademark

Trademark Overview

On Friday, August 7, 2020, a trademark application was filed for SYNKIR with the United States Patent and Trademark Office. The USPTO has given the SYNKIR trademark a serial number of 90099742. The federal status of this trademark filing is REGISTERED as of Tuesday, June 3, 2025. This trademark is owned by Verismo Therapeutics, Inc. . The SYNKIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer for use in Chimeric Antigen Receptor (CAR) T-Cell Therapy
synkir

General Information

Serial Number90099742
Word MarkSYNKIR
Filing DateFriday, August 7, 2020
Status700 - REGISTERED
Status DateTuesday, June 3, 2025
Registration Number7819263
Registration DateTuesday, June 3, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2021

Trademark Statements

Pseudo MarkSINKER;
Certificate of Correction for RegistrationIn the statement, line 1, Verismo Therapeutics, should be deleted, and, Verismo Therapeutics, Inc., should be inserted, and, line 1, PENNSYLVANIA, should be deleted, and, DELAWARE, should be inserted. 
Goods and ServicesPharmaceutical products for the treatment of cancer for use in Chimeric Antigen Receptor (CAR) T-Cell Therapy
Pseudo MarkSYN KIR

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 7, 2021
Primary Code005
First Use Anywhere DateThursday, May 2, 2024
First Use In Commerce DateThursday, May 2, 2024

Trademark Owner History

Party NameVerismo Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameVerismo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameVerismo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMount Laurel, NJ 08054

Trademark Events

Event DateEvent Description
Tuesday, August 11, 2020NEW APPLICATION ENTERED
Wednesday, September 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 2, 2020ASSIGNED TO EXAMINER
Friday, December 11, 2020NON-FINAL ACTION WRITTEN
Friday, December 11, 2020NON-FINAL ACTION E-MAILED
Friday, December 11, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 30, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 20, 2021PUBLISHED FOR OPPOSITION
Tuesday, July 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 14, 2021ASSIGNED TO EXAMINER
Sunday, March 13, 2022SOU TEAS EXTENSION RECEIVED
Sunday, March 13, 2022SOU EXTENSION 1 FILED
Sunday, March 13, 2022SOU EXTENSION 1 GRANTED
Tuesday, March 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, September 13, 2022SOU EXTENSION 2 FILED
Tuesday, September 13, 2022SOU EXTENSION 2 GRANTED
Thursday, September 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 13, 2023SOU EXTENSION 3 FILED
Monday, March 13, 2023SOU EXTENSION 3 GRANTED
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023SOU EXTENSION 4 FILED
Wednesday, September 13, 2023SOU EXTENSION 4 GRANTED
Friday, September 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 14, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 14, 2024SOU EXTENSION 5 FILED
Thursday, March 14, 2024SOU EXTENSION 5 GRANTED
Friday, March 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 6, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, October 10, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 6, 2024USE AMENDMENT FILED
Friday, October 11, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, November 18, 2024SU - NON-FINAL ACTION - WRITTEN
Monday, November 18, 2024NON-FINAL ACTION E-MAILED
Monday, November 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 18, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 26, 2025ASSIGNED TO LIE
Wednesday, February 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 12, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 12, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 3, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, June 3, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 10, 2025TEAS SECTION 7 REQUEST RECEIVED
Monday, September 22, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 30, 2025CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, October 21, 2025NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

Related Keywords

synkir receptor cell therapy antigen chimeric products treatment cancer pharmaceutical